XML 16 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements Of Stockholders' Equity - USD ($)
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income
Noncontrolling Interest [Member]
Balance, beginning of year at Dec. 31, 2015 $ 142,777,080 $ 1 $ 131,186,866 $ 11,483,015 $ 107,198
Balance, beginning of year, shares at Dec. 31, 2015   1,949,797      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income attributable to the Company 1,814,040   1,814,040    
Dividends (309,104)   (309,104)    
Shares of common stock repurchased and retired (in shares)   (18,795)      
Shares of common stock repurchased and retired (1,626,668)   (1,626,668)    
Stock options and stock appreciation rights exercised (in shares)   1,289      
Stock options and stock appreciation rights exercised (200)   (200)    
Share-based compensation expense 35,053   35,053    
Amortization related to postretirement health benefits 1,475     1,475  
Net unrealized gain on investments 699,846     699,846  
Net loss attributable to noncontrolling interests (9,579)       (9,579)
Income tax benefit from share-based compensation 32,292   32,292    
Balance, end of year at Mar. 31, 2016 143,414,235 $ 1 131,132,279 12,184,336 97,619
Balance, end of year, shares at Mar. 31, 2016   1,932,291      
Balance, beginning of year at Dec. 31, 2016 155,135,954 $ 1 143,283,621 11,761,447 90,885
Balance, beginning of year, shares at Dec. 31, 2016   1,884,283      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income attributable to the Company 4,476,055   4,476,055    
Dividends (377,218)   (377,218)    
Shares of common stock repurchased and retired (in shares)   (70)      
Shares of common stock repurchased and retired (8,986)   (8,986)    
Stock options and stock appreciation rights exercised (in shares)   1,875      
Stock options and stock appreciation rights exercised (380)   (380)    
Share-based compensation expense 32,348   32,348    
Amortization related to postretirement health benefits 1,422     1,422  
Net unrealized gain on investments 1,038,250     1,038,250  
Net loss attributable to noncontrolling interests (9,875)       (9,875)
Balance, end of year at Mar. 31, 2017 $ 160,287,570 $ 1 $ 147,405,440 $ 12,801,119 $ 81,010
Balance, end of year, shares at Mar. 31, 2017   1,886,088